Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - TOTAL CURRENT LIABILITIES
Total Current Liabilities ELVN - Enliven Therapeutics, Inc.
25.9 M
LAST VALUE
112.15%
2 YEAR CAGR
69.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR